Caitong International Asset Management Co., Ltd
Position in BMY — Bristol Myers Squibb Co
CIK 1963355
HONG KONG, K3
Position in BMY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$258,425
-$169,123 QoQ
Shares Held
4,485
-52.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,968
of 2,506 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caitong International Asset Management Co., Ltd holds $9,469,596 across 12 Drug Manufacturers - General names. BMY ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,347 | $6,413,352 | |
| 2 | MRK |
Merck & Co., Inc.
|
9,320 | $1,197,620 | |
| 3 | JNJ |
Johnson & Johnson
|
2,986 | $758,354 | |
| 4 | GSK |
GSK plc
|
10,104 | $529,651 | |
| 5 | NVS |
Novartis AG
|
1,799 | $281,939 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
4,485 | $258,425 | |
| 7 | OGN |
Organon & Co.
|
1,989 | $26,931 | |
| 8 | BIIB |
Biogen Inc.
|
14 | $3,024 |
All Filings in BMY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,425 | 4,485 | Shares | Sole | 2026-08-05 | |
| 2025-09-30 | $427,548 | 9,480 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $280,517 | 6,060 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,012 | 33 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||